Monoclonal antibodies like anti‐PD‐1/PD‐L1 agents and anti‐CTLA‐4 antibodies, cancer vaccines, oncolytic viruses and adoptive T cell therapy have been discussed in brief. Here, CTLA4 is linked to cancer.